Zagotenemab (MAPT) - Onderzoeksgrade Biosimilar
Gecertificeerd

Zagotenemab (MAPT) - Onderzoeksgrade Biosimilar

Catalog #: 11-008
Maat: 0.1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

Zagotenemab is an antibody drug that targets TAU protein, and has started Phase II clinical trial in April 2018.

Immunogen

Humanized / MAPT [Homo sapiens]

Clonality

• Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Neuroscience

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Fragment

IgG4-kappa

NCBI Organism

Homo sapiens

Other Product Names

LY-3303560

Beschrijving

Zagotenemab (MAPT) - Onderzoeksgrade Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamZagotenemab (MAPT) - Onderzoeksgrade Biosimilar
Categorie
Beschikbare grootte0.1 mg
Catalogusnummer11-008